Case Report: First-Line Immune Checkpoint Inhibitor Plus Chemotherapy for Oral Metastasis in a Patient with Ultra High-Risk Gestational Choriocarcinoma

Case Report: First-Line Immune Checkpoint Inhibitor Plus Chemotherapy for Oral Metastasis in a Patient with Ultra High-Risk Gestational Choriocarcinoma

Yu Chen,1,* Haiyan Ye,2,* Jiming Tang,3 Yihan Weng,4 Jie Zhang,5 Jianhua Liu4 1Department of Pathology, Guangdong Provincial People’s Hospital, Second Clinical Medical College of Southern Medical University, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, People’s Republ...

Full description

Bibliographic Details
Main Authors: Chen Y, Ye H, Tang J, Weng Y, Zhang J, Liu J
Format: Article
Language:English
Published: Dove Medical Press 2022-06-01
Series:Cancer Management and Research
Subjects:
choriocarcinoma
oral metastasis
ultra high-risk
immunotherapy
Online Access:https://www.dovepress.com/case-report-first-line-immune-checkpoint-inhibitor-plus-chemotherapy-f-peer-reviewed-fulltext-article-CMAR

Internet

https://www.dovepress.com/case-report-first-line-immune-checkpoint-inhibitor-plus-chemotherapy-f-peer-reviewed-fulltext-article-CMAR

Similar Items